IL6 and congenital rubella syndrome: A recent retrospective, multicenter study of 150 confirmed COVID-19 cases revealed that elevated IL-6 was a predictor of mortality, indicating that IL-6 played a central role in the hyperinflammation and CRS in the critical patients (11).